Combining lung ultrasound and Wells score for diagnosing pulmonary embolism in critically ill COVID-19 patients.


Journal

Journal of thrombosis and thrombolysis
ISSN: 1573-742X
Titre abrégé: J Thromb Thrombolysis
Pays: Netherlands
ID NLM: 9502018

Informations de publication

Date de publication:
Jul 2021
Historique:
accepted: 24 10 2020
pubmed: 5 11 2020
medline: 22 7 2021
entrez: 4 11 2020
Statut: ppublish

Résumé

Subpleural consolidations have been found in lung ultrasound in patients with COVID-19, possibly deriving from pulmonary embolism (PE). The diagnostic utility of impact of lung ultrasound in critical-ill patients with COVID-19 for PE diagnostics however is unclear. We retrospectively evaluated all SARS-CoV2-associated ARDS patients admitted to our ICU between March 8th and May 31th 2020. They were enrolled in this study, when a lung ultrasound and a computed tomography pulmonary angiography (CTPA) were documented. In addition, wells score was calculated to estimate the probability of PE. The CTPA was used as the gold standard for the detection of PE. Twenty out of 25 patients met the inclusion criteria. In 12/20 patients (60%) (sub-) segmental PE were detected by CT-angiography. Lung ultrasound found subpleural consolidations in 90% of patients. PE-typical large supleural consolidations with a size ≥ 1 cm were detectable in 65% of patients and were significant more frequent in patients with PE compared to those without (p = 0.035). Large consolidations predicted PE with a sensitivity of 77% and a specificity of 71%. The Wells score was significantly higher in patients with PE compared to those without (2.7 ± 0.8 and 1.7 ± 0.5, respectively, p = 0.042) and predicted PE with an AUC of 0.81. When combining the two modalities, comparing patients with considered/probable PE using LUS plus a Wells score ≥ 2 to patients with possible/unlikely PE in LUS plus a Wells score < 2, PE could be predicted with a sensitivity of 100% and a specificity of 80%. Large consolidations detected in lung ultrasound were found frequently in COVID-19 ARDS patients with pulmonary embolism. In combination with a Wells score > 2, this might indicate a high-risk for PE in COVID-19.

Identifiants

pubmed: 33145663
doi: 10.1007/s11239-020-02323-0
pii: 10.1007/s11239-020-02323-0
pmc: PMC7608377
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-84

Informations de copyright

© 2020. The Author(s).

Références

CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for 395 Global Evaluation and Research in Sepsis, Helms J, Tacquard C et al (2020) High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. https://doi.org/10.1007/s00134-020-06062-x
doi: 10.1007/s00134-020-06062-x pubmed: 33141245
Llitjos J, Leclerc M, Chochois C et al (2020) High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. https://doi.org/10.1111/jth.14869
doi: 10.1111/jth.14869 pubmed: 32320517
Klok FA, Kruip MJHA, van der Meer NJM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. https://doi.org/10.1016/j.thromres.2020.04.013
doi: 10.1016/j.thromres.2020.04.013 pubmed: 33535120
Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844–847. https://doi.org/10.1111/jth.14768
doi: 10.1111/jth.14768 pubmed: 7166509
Chung M, Bernheim A, Mei X et al (2020) CT imaging features of 2019 Novel Coronavirus (2019-nCoV). Radiology 295:202–207. https://doi.org/10.1148/radiol.2020200230
doi: 10.1148/radiol.2020200230 pubmed: 32017661
Zhu J, Zhong Z, Li H et al (2020) CT imaging features of 4121 patients with COVID-19: a meta-analysis. J Med Virol. https://doi.org/10.1002/jmv.25910
doi: 10.1002/jmv.25910 pubmed: 33230830
Zieleskiewicz L, Markarian T, Lopez A et al (2020) Comparative study of lung ultrasound and chest computed tomography scan in the assessment of severity of confirmed COVID-19 pneumonia. Intensive Care Med. https://doi.org/10.1007/s00134-020-06186-0
doi: 10.1007/s00134-020-06186-0 pubmed: 32728966
Peng Q-Y, Wang X-T, Zhang L-N (2020) Findings of lung ultrasonography of novel corona virus pneumonia during the. Intensive Care Med 46:849–850. https://doi.org/10.1007/s00134-020-05996-6
doi: 10.1007/s00134-020-05996-6 pubmed: 32166346
Volpicelli G, Lamorte A, Villén T (2020) What’s new in lung ultrasound during the COVID-19 pandemic. Intensive Care Med 46:1445–1448. https://doi.org/10.1007/s00134-020-06048-9
doi: 10.1007/s00134-020-06048-9 pubmed: 32367169
Manivel V, Lesnewski A, Shamim S et al (2020) CLUE: COVID-19 lung ultrasound in emergency department. Emerg Med Australas 32:694–696. https://doi.org/10.1111/1742-6723.13546
doi: 10.1111/1742-6723.13546 pubmed: 32386264
Zotzmann V, Lang CN, Bamberg F et al (2020) Are subpleural consolidations indicators for segmental pulmonary embolism in. Intensive Care Med 46:1109–1110. https://doi.org/10.1007/s00134-020-06044-z
doi: 10.1007/s00134-020-06044-z pubmed: 32328727
Alhazzani W, Møller MH, Arabi YM et al (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 46:854–887. https://doi.org/10.1007/s00134-020-06022-5
doi: 10.1007/s00134-020-06022-5 pubmed: 32222812
Lichtenstein DA, Mezière GA (2008) Relevance of lung ultrasound in the diagnosis of acute respiratory failure*: the BLUE protocol. Chest 134:117–125. https://doi.org/10.1378/chest.07-2800
doi: 10.1378/chest.07-2800 pubmed: 18403664
Mathis G, Blank W, Reissig A et al (2005) Thoracic ultrasound for diagnosing pulmonary embolism: a prospective multicenter study of 352 patients. Chest 128:1531–1538. https://doi.org/10.1378/chest.128.3.1531
doi: 10.1378/chest.128.3.1531 pubmed: 16162754
Moore AJE, Wachsmann J, Chamarthy MR et al (2018) Imaging of acute pulmonary embolism: an update. Cardiovasc Diagn Ther 8:225–243
doi: 10.21037/cdt.2017.12.01
Wells PS, Anderson DR, Rodger M et al (2001) Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med 135:98–107. https://doi.org/10.7326/0003-4819-135-2-200107170-00010
doi: 10.7326/0003-4819-135-2-200107170-00010 pubmed: 11453709
Nouvenne A, Zani MD, Milanese G et al (2020) Lung ultrasound in COVID-19 pneumonia: correlations with chest CT on Hospital admission. Respiration. https://doi.org/10.1159/000509223
doi: 10.1159/000509223 pubmed: 32570265
Smargiassi A, Soldati G, Borghetti A et al (2020) Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic. J Ultrasound. https://doi.org/10.1007/s40477-020-00501-7
doi: 10.1007/s40477-020-00501-7 pubmed: 32638333
Reißig A, Heyne JP, Kroegel C (2000) Diagnosis of pulmonary embolism employing transthoracic sonography: comparison with helical computed tomography. Am J Respir Crit Care Med 161:A757
Reissig A, Heyne J-P, Kroegel C (2004) Ancillary lung parenchymal findings at spiral CT scanning in pulmonary embolism. Relationship to chest sonography. Eur J Radiol 49:250–257. https://doi.org/10.1016/S0720-048X(03)00141-4
doi: 10.1016/S0720-048X(03)00141-4 pubmed: 14962655
Trenker C, Apitzsch JC, Pastor S et al (2017) Detection of peripheral embolic consolidations using contrast-enhanced ultrasonography in patients with no evidence of pulmonary embolism on computed tomography: a pilot study. J Clin Ultrasound 45:575–579. https://doi.org/10.1002/jcu.22511
doi: 10.1002/jcu.22511 pubmed: 28677845
Trenker C, Dohse M, Ramaswamy A et al (2019) Histological validation of pulmonary infarction detected with contrast-enhanced ultrasound in patients with negative computed tomography pulmonary angiogram: a case series. J Clin Ultrasound 47:461–465. https://doi.org/10.1002/jcu.22755
doi: 10.1002/jcu.22755 pubmed: 31332794
Joly BS, Siguret V, Veyradier A (2020) Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med 46:1603–1606. https://doi.org/10.1007/s00134-020-06088-1
doi: 10.1007/s00134-020-06088-1 pubmed: 32415314

Auteurs

Viviane Zotzmann (V)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. viviane.zotzmann@universitaets-herzzentrum.de.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. viviane.zotzmann@universitaets-herzzentrum.de.

Corinna N Lang (CN)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Tobias Wengenmayer (T)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Xavier Bemtgen (X)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Bonaventura Schmid (B)

Department of Emergency Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Katharina Mueller-Peltzer (K)

Department of Diagnostic and Interventional Radiology, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Alexander Supady (A)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany.

Christoph Bode (C)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Daniel Duerschmied (D)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Dawid L Staudacher (DL)

Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany.
Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH